Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin maintenance therapy in primary ciliary dyskinesia
NL-OMON42237Phase 4Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in primary ciliary dyskinesia (PCD) comparing Azithromycin maintenance therapy with Placebo (2 arms). Primary endpoint: Respiratory system exacerbations over 6 months. Started Feb 2015; status: active, not recruiting.
02
Drugs
azithromycin
03
Conditions
primary ciliary dyskinesia (PCD)
Beyond the preview
Go deeper on NL-OMON42237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42237.